Primary Cutaneous Cryptococcosis Treated with Debridement and Fluconazole Monotherapy in an Immunosuppressed Patient: A Case Report and Review of the Literature

Cryptococcus neoformans is an opportunistic yeast present in the environment. Practitioners are familiar with the presentation and management of the most common manifestation of cryptococcal infection, meningoencephalitis, in patients with AIDS or other conditions of immunocompromise. There is less...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer Wang, Luther Bartelt, Deborah Yu, Anjali Joshi, Bradley Weinbaum, Tiffany Pierson, Michael Patrizio, Cirle A. Warren, Molly A. Hughes, Gerald Donowitz
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Case Reports in Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2015/131356
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565004340035584
author Jennifer Wang
Luther Bartelt
Deborah Yu
Anjali Joshi
Bradley Weinbaum
Tiffany Pierson
Michael Patrizio
Cirle A. Warren
Molly A. Hughes
Gerald Donowitz
author_facet Jennifer Wang
Luther Bartelt
Deborah Yu
Anjali Joshi
Bradley Weinbaum
Tiffany Pierson
Michael Patrizio
Cirle A. Warren
Molly A. Hughes
Gerald Donowitz
author_sort Jennifer Wang
collection DOAJ
description Cryptococcus neoformans is an opportunistic yeast present in the environment. Practitioners are familiar with the presentation and management of the most common manifestation of cryptococcal infection, meningoencephalitis, in patients with AIDS or other conditions of immunocompromise. There is less awareness, however, of uncommon presentations where experience rather than evidence guides therapy. We report a case of primary cutaneous cryptococcosis (PCC) in a patient who had been immunosuppressed by chronic high-dose corticosteroid for the treatment of severe asthma. This case highlights the importance of early recognition of aggressive cellulitis that fails standard empiric antibiotic treatment in an immunocompromised patient. It also demonstrates successful treatment of PCC with a multispecialty approach including local debridement and fluconazole monotherapy.
format Article
id doaj-art-06ada05c37d948d691bfdd3354f4607a
institution Kabale University
issn 2090-6625
2090-6633
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Case Reports in Infectious Diseases
spelling doaj-art-06ada05c37d948d691bfdd3354f4607a2025-02-03T01:09:41ZengWileyCase Reports in Infectious Diseases2090-66252090-66332015-01-01201510.1155/2015/131356131356Primary Cutaneous Cryptococcosis Treated with Debridement and Fluconazole Monotherapy in an Immunosuppressed Patient: A Case Report and Review of the LiteratureJennifer Wang0Luther Bartelt1Deborah Yu2Anjali Joshi3Bradley Weinbaum4Tiffany Pierson5Michael Patrizio6Cirle A. Warren7Molly A. Hughes8Gerald Donowitz9School of Medicine, University of Virginia, Charlottesville, VA 22903, USADivision of Infectious Diseases, Department of Internal Medicine, University of Virginia, Charlottesville, VA 22903, USADepartment of Plastic and Maxillofacial Surgery, University of Virginia, Charlottesville, VA 22903, USADepartment of Internal Medicine, University of Virginia, Charlottesville, VA 22903, USADepartment of Internal Medicine, University of Virginia, Charlottesville, VA 22903, USADepartment of Internal Medicine, University of Virginia, Charlottesville, VA 22903, USADepartment of Internal Medicine, University of Virginia, Charlottesville, VA 22903, USADivision of Infectious Diseases, Department of Internal Medicine, University of Virginia, Charlottesville, VA 22903, USADivision of Infectious Diseases, Department of Internal Medicine, University of Virginia, Charlottesville, VA 22903, USADivision of Infectious Diseases, Department of Internal Medicine, University of Virginia, Charlottesville, VA 22903, USACryptococcus neoformans is an opportunistic yeast present in the environment. Practitioners are familiar with the presentation and management of the most common manifestation of cryptococcal infection, meningoencephalitis, in patients with AIDS or other conditions of immunocompromise. There is less awareness, however, of uncommon presentations where experience rather than evidence guides therapy. We report a case of primary cutaneous cryptococcosis (PCC) in a patient who had been immunosuppressed by chronic high-dose corticosteroid for the treatment of severe asthma. This case highlights the importance of early recognition of aggressive cellulitis that fails standard empiric antibiotic treatment in an immunocompromised patient. It also demonstrates successful treatment of PCC with a multispecialty approach including local debridement and fluconazole monotherapy.http://dx.doi.org/10.1155/2015/131356
spellingShingle Jennifer Wang
Luther Bartelt
Deborah Yu
Anjali Joshi
Bradley Weinbaum
Tiffany Pierson
Michael Patrizio
Cirle A. Warren
Molly A. Hughes
Gerald Donowitz
Primary Cutaneous Cryptococcosis Treated with Debridement and Fluconazole Monotherapy in an Immunosuppressed Patient: A Case Report and Review of the Literature
Case Reports in Infectious Diseases
title Primary Cutaneous Cryptococcosis Treated with Debridement and Fluconazole Monotherapy in an Immunosuppressed Patient: A Case Report and Review of the Literature
title_full Primary Cutaneous Cryptococcosis Treated with Debridement and Fluconazole Monotherapy in an Immunosuppressed Patient: A Case Report and Review of the Literature
title_fullStr Primary Cutaneous Cryptococcosis Treated with Debridement and Fluconazole Monotherapy in an Immunosuppressed Patient: A Case Report and Review of the Literature
title_full_unstemmed Primary Cutaneous Cryptococcosis Treated with Debridement and Fluconazole Monotherapy in an Immunosuppressed Patient: A Case Report and Review of the Literature
title_short Primary Cutaneous Cryptococcosis Treated with Debridement and Fluconazole Monotherapy in an Immunosuppressed Patient: A Case Report and Review of the Literature
title_sort primary cutaneous cryptococcosis treated with debridement and fluconazole monotherapy in an immunosuppressed patient a case report and review of the literature
url http://dx.doi.org/10.1155/2015/131356
work_keys_str_mv AT jenniferwang primarycutaneouscryptococcosistreatedwithdebridementandfluconazolemonotherapyinanimmunosuppressedpatientacasereportandreviewoftheliterature
AT lutherbartelt primarycutaneouscryptococcosistreatedwithdebridementandfluconazolemonotherapyinanimmunosuppressedpatientacasereportandreviewoftheliterature
AT deborahyu primarycutaneouscryptococcosistreatedwithdebridementandfluconazolemonotherapyinanimmunosuppressedpatientacasereportandreviewoftheliterature
AT anjalijoshi primarycutaneouscryptococcosistreatedwithdebridementandfluconazolemonotherapyinanimmunosuppressedpatientacasereportandreviewoftheliterature
AT bradleyweinbaum primarycutaneouscryptococcosistreatedwithdebridementandfluconazolemonotherapyinanimmunosuppressedpatientacasereportandreviewoftheliterature
AT tiffanypierson primarycutaneouscryptococcosistreatedwithdebridementandfluconazolemonotherapyinanimmunosuppressedpatientacasereportandreviewoftheliterature
AT michaelpatrizio primarycutaneouscryptococcosistreatedwithdebridementandfluconazolemonotherapyinanimmunosuppressedpatientacasereportandreviewoftheliterature
AT cirleawarren primarycutaneouscryptococcosistreatedwithdebridementandfluconazolemonotherapyinanimmunosuppressedpatientacasereportandreviewoftheliterature
AT mollyahughes primarycutaneouscryptococcosistreatedwithdebridementandfluconazolemonotherapyinanimmunosuppressedpatientacasereportandreviewoftheliterature
AT geralddonowitz primarycutaneouscryptococcosistreatedwithdebridementandfluconazolemonotherapyinanimmunosuppressedpatientacasereportandreviewoftheliterature